Skip to main navigation
Skip to search
Skip to main content
Home
Profiles
Departments and Centers
Scholarly Works
Activities
Equipment
Grants
Prizes
Search by expertise, name or affiliation
Bioselective Targeting Dextran Bioconjugate Anti-Inflammatory/Immunosuppressant Therapy
Stephen Massia
(Inventor)
Arizona State University
Research output
:
Patent
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Bioselective Targeting Dextran Bioconjugate Anti-Inflammatory/Immunosuppressant Therapy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Dextrans
Immunosuppressive Agents
Anti-Inflammatory Agents
Inflammation
Autoimmune Diseases
Eye
Leukocytes
Fluid Therapy
Multiple Organ Failure
Colloids
Capillary Permeability
Graft Rejection
Immunologic Factors
Eye Diseases
Septic Shock
Optic Nerve
Human Body
Wounds and Injuries
Reperfusion Injury
Retina
Therapeutics
Research Personnel
Technology
Equipment and Supplies
Pharmaceutical Preparations